Product Description
Mechanisms of Action: COX1 Inhibitor,COX2 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Chile | China | Hungary | Ireland | Mexico | New Zealand | Pakistan | South Africa | Taiwan
Approved Indications: None
Known Adverse Events: None
Company: Center for Epidemiology and Health Research, Germany
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NCT00302835 | N/A |
Completed |
Kidney Failure, Chronic |
None |